Senseonics Holdings, Inc. (SENS)
NASDAQ: SENS · Real-Time Price · USD
7.70
-0.58 (-7.00%)
Feb 11, 2026, 4:00 PM EST - Market closed
Senseonics Holdings Revenue
Senseonics Holdings had revenue of $8.10M in the quarter ending September 30, 2025, with 89.89% growth. This brings the company's revenue in the last twelve months to $29.30M, up 31.94% year-over-year. In the year 2024, Senseonics Holdings had annual revenue of $22.47M with 0.37% growth.
Revenue (ttm)
$29.30M
Revenue Growth
+31.94%
P/S Ratio
10.18
Revenue / Employee
$250,410
Employees
117
Market Cap
314.61M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22.47M | 82.00K | 0.37% |
| Dec 31, 2023 | 22.39M | 6.00M | 36.62% |
| Dec 31, 2022 | 16.39M | 2.71M | 19.85% |
| Dec 31, 2021 | 13.68M | 8.73M | 176.32% |
| Dec 31, 2020 | 4.95M | -16.35M | -76.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Viemed Healthcare | 254.79M |
| OrthoPediatrics | 227.41M |
| Cerus | 199.19M |
| RxSight | 142.09M |
| Quanterix | 130.20M |
| Owlet | 99.64M |
| Delcath Systems | 79.60M |
| Sight Sciences | 76.05M |
SENS News
- 13 days ago - Senseonics Receives European Approval for Eversense 365, World's Longest-lasting Continuous Glucose Monitor - GlobeNewsWire
- 4 weeks ago - Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist™ Automated Insulin Delivery (AID) System - GlobeNewsWire
- 7 weeks ago - Senseonics: Eversense 365 Is A Game Changer For The CGM Industry - Seeking Alpha
- 3 months ago - Senseonics Holdings, Inc. (SENS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Senseonics Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time - GlobeNewsWire
- 4 months ago - Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update - GlobeNewsWire
- 5 months ago - Senseonics Holdings, Inc. (SENS) Eversense 365 Commercial Update Call (Transcript) - Seeking Alpha
- 5 months ago - Ascensia Diabetes Care Signs MOU to Transfer Eversense® CGM Distribution to Strategic Partner Senseonics - Business Wire